LivaNova PLC: Total Voting Rights

In accordance with Disclosure and Transparency Rule 5.6, LivaNova PLC
(the “Company”) hereby notifies the market that as of 31 March 2017, the
Company’s capital consists of 48,184,737 ordinary shares of £1.00 each.
The Company does not hold any shares in treasury.

Therefore, the total number of voting rights in the Company is
48,184,737. This figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are required
to notify their interests in, or a change to their interest in, the
Company under the Disclosure and Transparency Rules.

About LivaNova

LivaNova PLC is a global medical technology company built on nearly five
decades of experience and a relentless commitment to improve the lives
of patients around the world. LivaNova’s advanced technologies and
breakthrough treatments provide meaningful solutions for the benefit of
patients, healthcare professionals and healthcare systems. Headquartered
in London and with a presence in more than 100 countries worldwide, the
company employs approximately 4,600 employees.